comparemela.com

Page 6 - Jones Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inhibikase Therapeutics, Inc (IKT) CEO Milton Werner on Q2 2022 Results - Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:NASDAQ:IKT) Q2 2022 Earnings Conference Call August 15, 2022 8:00 a.m.

Joe frattaroliAlex loboJoseph frattaroliSoumit royDanya benMilton wernerMovement disorder society congressInhibikase therapeutics incJones researchUs food and drug administrationInhibikase therapeuticsConference call augustInhibikase therapeutic second quarterResults conferenceStern investorChief executive officer

Medicenna Therapeutics Corp (MDNA) CEO Fahar Merchant on Q1 2023 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q1 2023 Earnings Conference Call August 15, 2022, 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant -.

United statesLiz williamsMatt bieglerDavid martinCatherine novackMedicenna therapeutics corpCompany participantsJones researchDrug development summitMedicenna therapeuticsConference call augustFirst quarter fiscalDan ferryAnnual information formFahar merchantChief executive officer

Amryt Pharma plc (AMYT) CEO Joseph Wiley on Q2 2022 Results - Earnings Call Transcript

Amryt Pharma plc (NASDAQ:NASDAQ:AMYT) Q2 2022 Earnings Conference Call August 04, 2022 08:30 AM ET Company Participants Simon Loughrey - Group Financial Controller Joseph Wiley - Chief.

United statesUnited kingdomSaudi arabiaSimon loughreyMax herrmannBrian whiteRory nealonDouglas tsaoMani forooharHelen phillipsTracy cunninghamAmryt pharmaJordi casalsJoe wileyJoseph wileyBrandon folkes

vimarsana © 2020. All Rights Reserved.